Dare Bioscience, Inc. Research and Development in Process
Dare Bioscience, Inc. (DARE) reported Research and Development in Process of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2021-03-30
- Dare Bioscience, Inc. research and development in process for the quarter ending 2019-12-31 was -$202.10K.
- Dare Bioscience, Inc. research and development in process for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. research and development in process for the quarter ending 2018-12-31 was $0.00.
- Dare Bioscience, Inc. research and development in process for the quarter ending 2018-09-30 was $55.00K.
- Dare Bioscience, Inc. research and development in process for fiscal 2020 was $0.00.
- Dare Bioscience, Inc. research and development in process for fiscal 2019 was -$202.10K, a 139.86% decline from fiscal 2018.
- Dare Bioscience, Inc. research and development in process for fiscal 2018 was $507.00K.
- Dare Bioscience, Inc. research and development in process for fiscal 2017 was $0.00.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month | Research and Development in Process 100 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-30 | ||||
| 2019-12-31 | -$202.10K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$202.10K derived: sum of 2 quarters · filed 2021-03-30 | -$202.10K 10-K · filed 2021-03-30 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $55.00K derived: sum of 2 quarters · filed 2020-03-27 | $507.00K 10-K · filed 2020-03-27 | ||
| 2018-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $507.00K 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $452.00K 10-Q · filed 2019-08-14 | ||||
| 2017-12-31 | $0.00 10-K · filed 2019-04-01 | ||||
| 2014-03-31 | $202.00K 10-Q · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |